Table 1 Clinicopathological characteristics of the patients (tissue cohort).
From: Fibrinogen alpha and beta chains as non-invasive predictors of hepatocellular carcinoma progression
Variable | n = 86 |
|---|---|
Age (years), mean ± SD | 56.2 ± 10.0 |
Male sex, n (%) | 67 (77.9) |
Etiology, n (%) | |
†HBV | 77 (89.5) |
‡HCV | 6 (7.0) |
Alcohol | 1 (1.2) |
HBV + Alcohol | 2 (2.3) |
Cirrhosis | 41 (56.9) |
§AST, IU/L | 56.3 (90.8) |
¶ALT, IU/L | 50.9 (62.8) |
Platelet, × 103/µL | 176.5 (55.2) |
††AFP, (ng/mL), mean ± SD | 2707.5 (8382.3) |
‡‡PIVKA-II, mAU/mL | 6887.1 (16742.7) |
Albumin (g/dL), mean ± SD | 4.4 (0.8) |
Total bilirubin (mg/dL), mean ± SD | 0.91 (1.2) |
Creatinine (mg/dL), mean ± SD | 0.90 (0.25) |
Sodium, mmol/L | 139.2 (2.1) |
Macrovascular invasion | 24 (32.4) |
Lymph node metastasis | 1 (1.3) |
Distant metastasis | 5 (6.6) |
Modified UICC stage, n (%) | |
I | 24 (27.9) |
II | 32 (37.2) |
III | 24 (27.9) |
IVA | 2 (2.3) |
IVB | 4 (4.6) |
